DURECT

Felix Theeuwes, D.Sc.,
Chairman and Chief Scientific Officer
James E. Brown, D.V.M,.
President and Chief Executive Officer
Michael H. Arenberg,
Senior Vice President, Corporate and Business Development
David J. Ellis, M.D., Ph.D.,
Vice President, Clinical and Regulatory Affairs
John W. Gibson, M.S.,
Vice President, Birmingham Operations and Principal Scientist
Steve Helmer,
Vice President, Chief Patent Counsel
Matthew J. Hogan,
Chief Financial Officer
Judy Joice,
Vice President, Operations and Corporate Quality Assurance
Jian Li,
Vice President, Finance and Corporate Controller
WeiQi Lin, M.D., Ph.D.,
Vice President, R&D Business Development & Principal Scientist
Andrew R. Miksztal, Ph.D,
Vice President, Pharmaceutical Research and Development
Su IL Yum, Ph.D.,
Executive Vice President, Pharmaceutical Systems R&D and Principal Engineer

Felix Theeuwes, D.Sc.,
Chairman and Chief Scientific Officer
James E. Brown, D.V.M.,
President and Chief Executive Officer
Simon X. Benito,
Director
Dr. Terrence F. Blaschke,
Director
Michael D. Casey,
Director
David R. Hoffmann,
Director, Lead Independent Director
Armand P. Neukermans Ph.D.,
Director
Jon S. Saxe,
Director